Loading…

Arylamines QSAR-Based Design and Molecular Dynamics of New Phenylthiophene and Benzimidazole Derivatives with Affinity for the C111, Y268, and H73 Sites of SARS-CoV-2 PLpro Enzyme

A non-structural SARS-CoV-2 protein, PLpro, is involved in post-translational modifications in cells, allowing the evasion of antiviral immune response mechanisms. In this study, potential PLpro inhibitory drugs were designed using QSAR, molecular docking, and molecular dynamics. A combined QSAR equ...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceuticals (Basel, Switzerland) Switzerland), 2024-05, Vol.17 (5), p.606
Main Authors: Sabadini, Gianfranco, Mellado, Marco, Morales, César, Mella, Jaime
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c484t-7ce0b3869c18a94c5d077f82b3b359cfdd22cc1f0b4d047478ef8e2680f396813
cites cdi_FETCH-LOGICAL-c484t-7ce0b3869c18a94c5d077f82b3b359cfdd22cc1f0b4d047478ef8e2680f396813
container_end_page
container_issue 5
container_start_page 606
container_title Pharmaceuticals (Basel, Switzerland)
container_volume 17
creator Sabadini, Gianfranco
Mellado, Marco
Morales, César
Mella, Jaime
description A non-structural SARS-CoV-2 protein, PLpro, is involved in post-translational modifications in cells, allowing the evasion of antiviral immune response mechanisms. In this study, potential PLpro inhibitory drugs were designed using QSAR, molecular docking, and molecular dynamics. A combined QSAR equation with physicochemical and Free-Wilson descriptors was formulated. The r , q , and r values were 0.833, 0.770, and 0.721, respectively. From the equation, it was found that the presence of an aromatic ring and a basic nitrogen atom is crucial for obtaining good antiviral activity. Then, a series of structures for the binding sites of C111, Y268, and H73 of PLpro were created. The best compounds were found to exhibit pIC values of 9.124 and docking scoring values of -14 kcal/mol. The stability of the compounds in the cavities was confirmed by molecular dynamics studies. A high number of stable contacts and good interactions over time were exhibited by the aryl-thiophenes Pred14 and Pred15, making them potential antiviral candidates.
doi_str_mv 10.3390/ph17050606
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_96613e1ff62348889017a07c566edf24</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A795450133</galeid><doaj_id>oai_doaj_org_article_96613e1ff62348889017a07c566edf24</doaj_id><sourcerecordid>A795450133</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-7ce0b3869c18a94c5d077f82b3b359cfdd22cc1f0b4d047478ef8e2680f396813</originalsourceid><addsrcrecordid>eNptks9uEzEQxlcIREvhwgMgS1wQ6hZ77bW9xzT9KwUoBJA4rRzvOHG0awd702rzWrwgblJaQMgHj0a_75sZzWTZS4KPKK3wu9WCCFxijvmjbJ-wguWyYOLxH_Fe9izGJcalIIw8zfaoFBUjQuxnP0dhaFVnHUT0aTr6nB-rCA06gWjnDinXoPe-Bb1uVUAng0ukjsgb9AFu0NUC3ND2C-tXKYItfQxuYzvbqE2SJZtgr1Vvr5P7je0XaGSMdbYfkPEB9QtAY0LIIfpecHm41V8Iiqa2h22R1M80H_tveYGuJqvg0anbDB08z54Y1UZ4cfcfZF_PTr-ML_LJx_PL8WiSayZZnwsNeEYlrzSRqmK6bLAQRhYzOqNlpU3TFIXWxOAZazATTEgwElIn2NCKS0IPssudb-PVsl4F26kw1F7ZepvwYV6r0FvdQl1xTigQY3hBmZSywkQoLHTJOTSmYMnrzc4rjfFjDbGvOxs1tK1y4Nexpml9VJKC8IS-_gdd-nVwadJElRUvGeHlAzVXqb51xvdB6VvTeiSqkpWYUJqoo_9Q6TWQNukdGJvyfwne7gQ6-BgDmPu5Ca5vr61-uLYEv7rrdD3roLlHf58X_QWuN8o9</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3059654165</pqid></control><display><type>article</type><title>Arylamines QSAR-Based Design and Molecular Dynamics of New Phenylthiophene and Benzimidazole Derivatives with Affinity for the C111, Y268, and H73 Sites of SARS-CoV-2 PLpro Enzyme</title><source>PubMed Central(OA)</source><source>ProQuest - Publicly Available Content Database</source><source>Coronavirus Research Database</source><creator>Sabadini, Gianfranco ; Mellado, Marco ; Morales, César ; Mella, Jaime</creator><creatorcontrib>Sabadini, Gianfranco ; Mellado, Marco ; Morales, César ; Mella, Jaime</creatorcontrib><description>A non-structural SARS-CoV-2 protein, PLpro, is involved in post-translational modifications in cells, allowing the evasion of antiviral immune response mechanisms. In this study, potential PLpro inhibitory drugs were designed using QSAR, molecular docking, and molecular dynamics. A combined QSAR equation with physicochemical and Free-Wilson descriptors was formulated. The r , q , and r values were 0.833, 0.770, and 0.721, respectively. From the equation, it was found that the presence of an aromatic ring and a basic nitrogen atom is crucial for obtaining good antiviral activity. Then, a series of structures for the binding sites of C111, Y268, and H73 of PLpro were created. The best compounds were found to exhibit pIC values of 9.124 and docking scoring values of -14 kcal/mol. The stability of the compounds in the cavities was confirmed by molecular dynamics studies. A high number of stable contacts and good interactions over time were exhibited by the aryl-thiophenes Pred14 and Pred15, making them potential antiviral candidates.</description><identifier>ISSN: 1424-8247</identifier><identifier>EISSN: 1424-8247</identifier><identifier>DOI: 10.3390/ph17050606</identifier><identifier>PMID: 38794177</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Amino acids ; Analysis ; Antiviral agents ; Antiviral drugs ; Atazanavir ; Benzimidazoles ; Chemical properties ; coronavirus ; Coronaviruses ; COVID-19 ; Drugs ; Enzyme kinetics ; Enzymes ; Etravirine ; Free-Wilson ; Health aspects ; Hydrogen bonds ; Molecular dynamics ; Mortality ; Mutation ; PLpro ; Proteins ; QSAR ; RNA ; RNA polymerase ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; Structure ; Structure-activity relationship (Pharmacology) ; Structure-activity relationships ; Testing ; Thiophene ; Vaccines</subject><ispartof>Pharmaceuticals (Basel, Switzerland), 2024-05, Vol.17 (5), p.606</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c484t-7ce0b3869c18a94c5d077f82b3b359cfdd22cc1f0b4d047478ef8e2680f396813</citedby><cites>FETCH-LOGICAL-c484t-7ce0b3869c18a94c5d077f82b3b359cfdd22cc1f0b4d047478ef8e2680f396813</cites><orcidid>0000-0002-2434-8461 ; 0000-0001-9577-5180 ; 0009-0009-1925-3167</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3059654165/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3059654165?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,27924,27925,37012,37013,38516,43895,44590,74412,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38794177$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sabadini, Gianfranco</creatorcontrib><creatorcontrib>Mellado, Marco</creatorcontrib><creatorcontrib>Morales, César</creatorcontrib><creatorcontrib>Mella, Jaime</creatorcontrib><title>Arylamines QSAR-Based Design and Molecular Dynamics of New Phenylthiophene and Benzimidazole Derivatives with Affinity for the C111, Y268, and H73 Sites of SARS-CoV-2 PLpro Enzyme</title><title>Pharmaceuticals (Basel, Switzerland)</title><addtitle>Pharmaceuticals (Basel)</addtitle><description>A non-structural SARS-CoV-2 protein, PLpro, is involved in post-translational modifications in cells, allowing the evasion of antiviral immune response mechanisms. In this study, potential PLpro inhibitory drugs were designed using QSAR, molecular docking, and molecular dynamics. A combined QSAR equation with physicochemical and Free-Wilson descriptors was formulated. The r , q , and r values were 0.833, 0.770, and 0.721, respectively. From the equation, it was found that the presence of an aromatic ring and a basic nitrogen atom is crucial for obtaining good antiviral activity. Then, a series of structures for the binding sites of C111, Y268, and H73 of PLpro were created. The best compounds were found to exhibit pIC values of 9.124 and docking scoring values of -14 kcal/mol. The stability of the compounds in the cavities was confirmed by molecular dynamics studies. A high number of stable contacts and good interactions over time were exhibited by the aryl-thiophenes Pred14 and Pred15, making them potential antiviral candidates.</description><subject>Amino acids</subject><subject>Analysis</subject><subject>Antiviral agents</subject><subject>Antiviral drugs</subject><subject>Atazanavir</subject><subject>Benzimidazoles</subject><subject>Chemical properties</subject><subject>coronavirus</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Drugs</subject><subject>Enzyme kinetics</subject><subject>Enzymes</subject><subject>Etravirine</subject><subject>Free-Wilson</subject><subject>Health aspects</subject><subject>Hydrogen bonds</subject><subject>Molecular dynamics</subject><subject>Mortality</subject><subject>Mutation</subject><subject>PLpro</subject><subject>Proteins</subject><subject>QSAR</subject><subject>RNA</subject><subject>RNA polymerase</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Structure</subject><subject>Structure-activity relationship (Pharmacology)</subject><subject>Structure-activity relationships</subject><subject>Testing</subject><subject>Thiophene</subject><subject>Vaccines</subject><issn>1424-8247</issn><issn>1424-8247</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptks9uEzEQxlcIREvhwgMgS1wQ6hZ77bW9xzT9KwUoBJA4rRzvOHG0awd702rzWrwgblJaQMgHj0a_75sZzWTZS4KPKK3wu9WCCFxijvmjbJ-wguWyYOLxH_Fe9izGJcalIIw8zfaoFBUjQuxnP0dhaFVnHUT0aTr6nB-rCA06gWjnDinXoPe-Bb1uVUAng0ukjsgb9AFu0NUC3ND2C-tXKYItfQxuYzvbqE2SJZtgr1Vvr5P7je0XaGSMdbYfkPEB9QtAY0LIIfpecHm41V8Iiqa2h22R1M80H_tveYGuJqvg0anbDB08z54Y1UZ4cfcfZF_PTr-ML_LJx_PL8WiSayZZnwsNeEYlrzSRqmK6bLAQRhYzOqNlpU3TFIXWxOAZazATTEgwElIn2NCKS0IPssudb-PVsl4F26kw1F7ZepvwYV6r0FvdQl1xTigQY3hBmZSywkQoLHTJOTSmYMnrzc4rjfFjDbGvOxs1tK1y4Nexpml9VJKC8IS-_gdd-nVwadJElRUvGeHlAzVXqb51xvdB6VvTeiSqkpWYUJqoo_9Q6TWQNukdGJvyfwne7gQ6-BgDmPu5Ca5vr61-uLYEv7rrdD3roLlHf58X_QWuN8o9</recordid><startdate>20240501</startdate><enddate>20240501</enddate><creator>Sabadini, Gianfranco</creator><creator>Mellado, Marco</creator><creator>Morales, César</creator><creator>Mella, Jaime</creator><general>MDPI AG</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-2434-8461</orcidid><orcidid>https://orcid.org/0000-0001-9577-5180</orcidid><orcidid>https://orcid.org/0009-0009-1925-3167</orcidid></search><sort><creationdate>20240501</creationdate><title>Arylamines QSAR-Based Design and Molecular Dynamics of New Phenylthiophene and Benzimidazole Derivatives with Affinity for the C111, Y268, and H73 Sites of SARS-CoV-2 PLpro Enzyme</title><author>Sabadini, Gianfranco ; Mellado, Marco ; Morales, César ; Mella, Jaime</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-7ce0b3869c18a94c5d077f82b3b359cfdd22cc1f0b4d047478ef8e2680f396813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Amino acids</topic><topic>Analysis</topic><topic>Antiviral agents</topic><topic>Antiviral drugs</topic><topic>Atazanavir</topic><topic>Benzimidazoles</topic><topic>Chemical properties</topic><topic>coronavirus</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Drugs</topic><topic>Enzyme kinetics</topic><topic>Enzymes</topic><topic>Etravirine</topic><topic>Free-Wilson</topic><topic>Health aspects</topic><topic>Hydrogen bonds</topic><topic>Molecular dynamics</topic><topic>Mortality</topic><topic>Mutation</topic><topic>PLpro</topic><topic>Proteins</topic><topic>QSAR</topic><topic>RNA</topic><topic>RNA polymerase</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Structure</topic><topic>Structure-activity relationship (Pharmacology)</topic><topic>Structure-activity relationships</topic><topic>Testing</topic><topic>Thiophene</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sabadini, Gianfranco</creatorcontrib><creatorcontrib>Mellado, Marco</creatorcontrib><creatorcontrib>Morales, César</creatorcontrib><creatorcontrib>Mella, Jaime</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Pharmaceuticals (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sabadini, Gianfranco</au><au>Mellado, Marco</au><au>Morales, César</au><au>Mella, Jaime</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Arylamines QSAR-Based Design and Molecular Dynamics of New Phenylthiophene and Benzimidazole Derivatives with Affinity for the C111, Y268, and H73 Sites of SARS-CoV-2 PLpro Enzyme</atitle><jtitle>Pharmaceuticals (Basel, Switzerland)</jtitle><addtitle>Pharmaceuticals (Basel)</addtitle><date>2024-05-01</date><risdate>2024</risdate><volume>17</volume><issue>5</issue><spage>606</spage><pages>606-</pages><issn>1424-8247</issn><eissn>1424-8247</eissn><abstract>A non-structural SARS-CoV-2 protein, PLpro, is involved in post-translational modifications in cells, allowing the evasion of antiviral immune response mechanisms. In this study, potential PLpro inhibitory drugs were designed using QSAR, molecular docking, and molecular dynamics. A combined QSAR equation with physicochemical and Free-Wilson descriptors was formulated. The r , q , and r values were 0.833, 0.770, and 0.721, respectively. From the equation, it was found that the presence of an aromatic ring and a basic nitrogen atom is crucial for obtaining good antiviral activity. Then, a series of structures for the binding sites of C111, Y268, and H73 of PLpro were created. The best compounds were found to exhibit pIC values of 9.124 and docking scoring values of -14 kcal/mol. The stability of the compounds in the cavities was confirmed by molecular dynamics studies. A high number of stable contacts and good interactions over time were exhibited by the aryl-thiophenes Pred14 and Pred15, making them potential antiviral candidates.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>38794177</pmid><doi>10.3390/ph17050606</doi><orcidid>https://orcid.org/0000-0002-2434-8461</orcidid><orcidid>https://orcid.org/0000-0001-9577-5180</orcidid><orcidid>https://orcid.org/0009-0009-1925-3167</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1424-8247
ispartof Pharmaceuticals (Basel, Switzerland), 2024-05, Vol.17 (5), p.606
issn 1424-8247
1424-8247
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_96613e1ff62348889017a07c566edf24
source PubMed Central(OA); ProQuest - Publicly Available Content Database; Coronavirus Research Database
subjects Amino acids
Analysis
Antiviral agents
Antiviral drugs
Atazanavir
Benzimidazoles
Chemical properties
coronavirus
Coronaviruses
COVID-19
Drugs
Enzyme kinetics
Enzymes
Etravirine
Free-Wilson
Health aspects
Hydrogen bonds
Molecular dynamics
Mortality
Mutation
PLpro
Proteins
QSAR
RNA
RNA polymerase
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Structure
Structure-activity relationship (Pharmacology)
Structure-activity relationships
Testing
Thiophene
Vaccines
title Arylamines QSAR-Based Design and Molecular Dynamics of New Phenylthiophene and Benzimidazole Derivatives with Affinity for the C111, Y268, and H73 Sites of SARS-CoV-2 PLpro Enzyme
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T12%3A04%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Arylamines%20QSAR-Based%20Design%20and%20Molecular%20Dynamics%20of%20New%20Phenylthiophene%20and%20Benzimidazole%20Derivatives%20with%20Affinity%20for%20the%20C111,%20Y268,%20and%20H73%20Sites%20of%20SARS-CoV-2%20PLpro%20Enzyme&rft.jtitle=Pharmaceuticals%20(Basel,%20Switzerland)&rft.au=Sabadini,%20Gianfranco&rft.date=2024-05-01&rft.volume=17&rft.issue=5&rft.spage=606&rft.pages=606-&rft.issn=1424-8247&rft.eissn=1424-8247&rft_id=info:doi/10.3390/ph17050606&rft_dat=%3Cgale_doaj_%3EA795450133%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c484t-7ce0b3869c18a94c5d077f82b3b359cfdd22cc1f0b4d047478ef8e2680f396813%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3059654165&rft_id=info:pmid/38794177&rft_galeid=A795450133&rfr_iscdi=true